About the Company - Astec Lifesciences Ltd
Astec Lifesciences Ltd. is a Public Limited Listed company incorporated on 25/01/1994 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1994PLC076236 and registration number is 076236. Currently Company is involved in the business activities of Manufacture of insecticides, rodenticides, fungicides, herbicides. Company’s Total Operating Revenue is Rs. 676.57 Cr. and Equity Capital is Rs. 19.60 Cr. for the Year ended 31/03/2022.
Management |
---|
Name | Position Held |
---|
Mr. Nadir B Godrej | Chairman |
Mr. Ashok V Hiremath | Non Executive Director |
Mr. Balram Singh Yadav | Non Executive Director |
Mr. Anurag Roy | WholeTime Director & CEO |
Dr. Brahma Nand Vyas | Independent Director |
Mr. Vijay Kashinath Khot | Independent Director |
Mr. R R Govindan | Independent Director |
Mr. Nandkumar Dhekne | Independent Director |
Ms. Anjali Gupte | Independent Director |
Mr. Burjis Nadir Godrej | Non Executive Director |
Astec Lifesciences Ltd. Share Price Update |
---|
Share Price | Value |
---|
Today | ₹1,213.95 |
Previous Day | ₹1,190.15 |
Basic Stock Data of Astec Lifesciences Ltd
Market Cap | 2,343 Cr. |
---|
Current Price | 1,195 |
---|
High / Low | 1,957/1,045 |
---|
Stock P/E | |
---|
Book Value | 201 |
---|
Dividend Yield | 0.13 % |
---|
ROCE | 7.82 % |
---|
ROE | 6.36 % |
---|
Face Value | 10.0 |
---|
Astec Lifesciences Ltd Quarterly Results
Month | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|
Sales | 155 | 116 | 172 | 129 | 103 | 173 | 272 | 184 | 200 | 117 | 127 | 143 | 111 |
Expenses | 126 | 100 | 134 | 104 | 81 | 130 | 207 | 159 | 166 | 105 | 122 | 140 | 114 |
Operating Profit | 30 | 16 | 38 | 25 | 21 | 43 | 65 | 25 | 33 | 12 | 5 | 3 | -3 |
OPM % | 19% | 13% | 22% | 19% | 21% | 25% | 24% | 14% | 17% | 10% | 4% | 2% | -3% |
Other Income | 2 | 3 | 2 | 1 | 1 | 2 | 7 | 3 | 4 | 4 | 3 | 2 | 1 |
Interest | 1 | 1 | 1 | 2 | 2 | 3 | 3 | 4 | 5 | 6 | 6 | 6 | 6 |
Depreciation | 6 | 7 | 7 | 7 | 8 | 9 | 11 | 9 | 8 | 9 | 8 | 9 | 9 |
Profit before tax | 24 | 11 | 32 | 17 | 12 | 33 | 58 | 15 | 25 | 1 | -6 | -11 | -18 |
Tax % | 25% | 37% | 26% | 26% | 26% | 25% | 26% | 25% | 25% | 31% | 20% | 26% | 24% |
Net Profit | 18 | 7 | 24 | 13 | 9 | 25 | 43 | 11 | 18 | 1 | -5 | -8 | -13 |
EPS in Rs | 9.12 | 3.61 | 12.23 | 6.63 | 4.63 | 12.63 | 21.97 | 5.82 | 9.34 | 0.43 | -2.54 | -4.18 | -6.85 |
Astec Lifesciences Ltd Quarterly Chart
Astec Lifesciences Ltd Profit & Loss
Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|
Sales | 112 | 174 | 207 | 267 | 233 | 299 | 368 | 431 | 523 | 555 | 677 | 628 | 498 |
Expenses | 97 | 146 | 171 | 213 | 201 | 236 | 299 | 354 | 437 | 443 | 522 | 551 | 481 |
Operating Profit | 16 | 28 | 35 | 54 | 32 | 63 | 69 | 76 | 85 | 112 | 154 | 77 | 17 |
OPM % | 14% | 16% | 17% | 20% | 14% | 21% | 19% | 18% | 16% | 20% | 23% | 12% | 3% |
Other Income | 1 | 0 | -0 | -16 | 4 | -8 | 12 | 11 | 12 | 8 | 10 | 13 | 9 |
Interest | 6 | 7 | 9 | 13 | 13 | 12 | 11 | 12 | 13 | 5 | 9 | 21 | 25 |
Depreciation | 9 | 12 | 15 | 13 | 10 | 14 | 15 | 19 | 23 | 26 | 34 | 34 | 35 |
Profit before tax | 2 | 9 | 11 | 13 | 12 | 29 | 56 | 56 | 61 | 89 | 121 | 35 | -34 |
Tax % | 29% | 32% | 22% | -17% | 59% | 33% | 37% | 36% | 23% | 27% | 26% | 27% | |
Net Profit | 1 | 6 | 9 | 15 | 5 | 19 | 35 | 36 | 48 | 65 | 90 | 26 | -26 |
EPS in Rs | 0.81 | 3.30 | 4.68 | 7.60 | 2.55 | 9.80 | 17.87 | 18.28 | 24.28 | 33.21 | 45.85 | 13.04 | -13.14 |
Dividend Payout % | 62% | 23% | 21% | 16% | -0% | 15% | 8% | 8% | 6% | 5% | 3% | 12% | |
Astec Lifesciences Ltd Profit & Loss Yearly Chart
Astec Lifesciences Ltd Growth
|
Compounded Sales Growth |
---|
10 Years:: | 14% |
5 Years:: | 11% |
3 Years:: | 6% |
TTM:: | -40% |
Astec Lifesciences Ltd Growth
|
Compounded Profit Growth |
---|
10 Years:: | 16% |
5 Years:: | -4% |
3 Years:: | -18% |
TTM:: | -126% |
Astec Lifesciences Ltd Growth
|
Stock Price CAGR |
---|
10 Years:: | 45% |
5 Years:: | 18% |
3 Years:: | 4% |
1 Year:: | -37% |
Astec Lifesciences Ltd Growth
|
Return on Equity |
---|
10 Years:: | 17% |
5 Years:: | 18% |
3 Years:: | 17% |
Last Year:: | 6% |
No data available for the Balance Sheet data table.
Astec Lifesciences Ltd Reserves and Borrowings Chart
Astec Lifesciences Ltd Cash Flow
Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|
Cash from Operating Activity | -0 | 16 | 15 | 7 | -13 | 19 | 65 | 15 | 168 | -8 | 24 | 75 |
Cash from Investing Activity | -0 | -13 | -19 | -19 | -17 | -18 | -49 | -52 | -74 | -73 | -104 | -113 |
Cash from Financing Activity | -0 | -2 | 3 | 12 | 31 | -1 | -18 | 37 | -95 | 81 | 80 | 38 |
Net Cash Flow | -0 | 1 | -1 | -0 | 2 | 1 | -3 | -0 | 0 | 0 | 0 | -0 |
|
Astec Lifesciences Ltd Financial Efficiency Indicators
Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|
Debtor Days | 103 | 131 | 91 | 142 | 126 | 135 | 122 | 103 | 112 | 123 | 148 | 90 |
Inventory Days | 237 | 145 | 192 | 147 | 177 | 133 | 122 | 121 | 131 | 113 | 176 | 268 |
Days Payable | 146 | 132 | 114 | 179 | 169 | 116 | 155 | 83 | 218 | 137 | 179 | 161 |
Cash Conversion Cycle | 195 | 145 | 168 | 109 | 134 | 152 | 89 | 142 | 25 | 100 | 145 | 197 |
Working Capital Days | 179 | 122 | 125 | 125 | 142 | 154 | 115 | 147 | 77 | 101 | 163 | 175 |
ROCE % | 5% | 9% | 11% | 20% | 12% | 20% | 22% | 20% | 20% | 22% | 22% | 8% |
Astec Lifesciences Ltd Financial Efficiency Indicators Chart
Astec Lifesciences Ltd Share Holding Pattern
Month | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|
Promoters | 65.23% | 65.23% | 65.20% | 65.20% | 65.19% | 65.29% | 65.29% | 66.77% | 66.76% | 66.76% | 66.76% | 66.75% |
FIIs | 0.66% | 0.25% | 0.19% | 0.22% | 0.29% | 0.32% | 0.48% | 1.53% | 2.19% | 2.29% | 1.95% | 1.33% |
DIIs | 6.53% | 10.67% | 10.93% | 12.21% | 12.74% | 12.56% | 11.79% | 9.82% | 9.57% | 10.58% | 10.15% | 10.16% |
Public | 27.57% | 23.85% | 23.68% | 22.37% | 21.78% | 21.83% | 22.45% | 21.87% | 21.49% | 20.37% | 21.13% | 21.74% |
No. of Shareholders | 21,043 | 19,872 | 22,817 | 21,073 | 19,002 | 16,951 | 17,433 | 17,632 | 19,545 | 17,809 | 18,703 | 18,722 |
Astec Lifesciences Ltd Shareholding Pattern Chart
No. of Astec Lifesciences Ltd Shareholders
Astec Lifesciences Ltd Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) |
---|
Nippon India Small Cap Fund | 468589 | 0.17 | 62.02 |
ICICI Prudential Multicap Fund | 457669 | 0.69 | 60.58 |
ICICI Prudential Smallcap Fund | 452546 | 0.99 | 59.9 |
Nippon India Multi Cap Fund | 257718 | 0.16 | 34.11 |
ICICI Prudential Commodities Fund | 112360 | 1.12 | 14.87 |
ICICI Prudential MidCap Fund | 15844 | 0.05 | 2.1 |
ITI Value Fund | 11923 | 1.13 | 1.58 |
ITI Pharma and Healthcare Fund | 11754 | 1.15 | 1.56 |
Motilal Oswal Nifty Microcap 250 Index Fund | 5371 | 0.18 | 0.71 |
Astec Lifesciences Ltd ROCE Trend
Astec Lifesciences Ltd EPS Trend
Astec Lifesciences Ltd Key Financial Ratios
Month | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 |
---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 13.04 | 45.87 | 33.23 | 24.29 | 18.28 |
Diluted EPS (Rs.) | 13.04 | 45.85 | 33.21 | 24.27 | 18.26 |
Cash EPS (Rs.) | 30.22 | 63.39 | 46.32 | 36.13 | 28.19 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 214.00 | 202.40 | 157.91 | 126.17 | 103.72 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 214.00 | 202.40 | 157.91 | 126.17 | 103.72 |
Revenue From Operations / Share (Rs.) | 320.40 | 345.23 | 283.28 | 267.07 | 220.38 |
PBDIT / Share (Rs.) | 45.56 | 83.96 | 61.00 | 49.63 | 44.82 |
PBIT / Share (Rs.) | 28.39 | 66.43 | 47.90 | 37.79 | 34.92 |
PBT / Share (Rs.) | 17.82 | 61.81 | 45.47 | 31.35 | 28.59 |
Net Profit / Share (Rs.) | 13.05 | 45.86 | 33.22 | 24.29 | 18.29 |
NP After MI And SOA / Share (Rs.) | 13.04 | 45.85 | 33.21 | 24.28 | 18.28 |
PBDIT Margin (%) | 14.21 | 24.31 | 21.53 | 18.58 | 20.33 |
PBIT Margin (%) | 8.86 | 19.24 | 16.90 | 14.14 | 15.84 |
PBT Margin (%) | 5.56 | 17.90 | 16.05 | 11.73 | 12.97 |
Net Profit Margin (%) | 4.07 | 13.28 | 11.72 | 9.09 | 8.30 |
NP After MI And SOA Margin (%) | 4.06 | 13.28 | 11.72 | 9.09 | 8.29 |
Return on Networth / Equity (%) | 6.09 | 22.66 | 21.03 | 19.26 | 17.64 |
Return on Capital Employeed (%) | 12.28 | 32.05 | 26.40 | 29.18 | 32.16 |
Return On Assets (%) | 2.61 | 10.02 | 9.60 | 8.31 | 7.75 |
Long Term Debt / Equity (X) | 0.02 | 0.00 | 0.12 | 0.00 | 0.00 |
Total Debt / Equity (X) | 0.81 | 0.70 | 0.60 | 0.40 | 0.86 |
Asset Turnover Ratio (%) | 0.66 | 0.85 | 0.88 | 1.01 | 0.98 |
Current Ratio (X) | 0.94 | 1.05 | 1.03 | 1.04 | 0.99 |
Quick Ratio (X) | 0.38 | 0.67 | 0.69 | 0.66 | 0.62 |
Inventory Turnover Ratio (X) | 1.91 | 3.04 | 3.03 | 3.12 | 3.44 |
Dividend Payout Ratio (NP) (%) | 11.50 | 3.26 | 4.51 | 6.17 | 8.20 |
Dividend Payout Ratio (CP) (%) | 4.96 | 2.36 | 3.23 | 4.15 | 5.32 |
Earning Retention Ratio (%) | 88.50 | 96.74 | 95.49 | 93.83 | 91.80 |
Cash Earning Retention Ratio (%) | 95.04 | 97.64 | 96.77 | 95.85 | 94.68 |
Interest Coverage Ratio (%) | 4.31 | 18.17 | 25.15 | 7.71 | 7.08 |
Interest Coverage Ratio (Post Tax) (%) | 2.24 | 10.92 | 14.69 | 4.77 | 3.89 |
Enterprise Value (Cr.) | 3049.60 | 3711.79 | 2144.94 | 880.19 | 1227.61 |
EV / Net Operating Revenue (X) | 4.85 | 5.49 | 3.87 | 1.68 | 2.85 |
EV / EBITDA (X) | 34.14 | 22.56 | 17.95 | 9.06 | 14.01 |
MarketCap / Net Operating Revenue (X) | 4.31 | 5.08 | 3.53 | 1.50 | 2.44 |
Retention Ratios (%) | 88.49 | 96.73 | 95.48 | 93.82 | 91.79 |
Price / BV (X) | 6.46 | 8.66 | 6.34 | 3.17 | 5.20 |
Price / Net Operating Revenue (X) | 4.31 | 5.08 | 3.53 | 1.50 | 2.44 |
EarningsYield | 0.01 | 0.02 | 0.03 | 0.06 | 0.03 |
Astec Lifesciences Ltd Profitability Ratios (%)
Astec Lifesciences Ltd Liquidity Ratios
Astec Lifesciences Ltd Liquidity Ratios (%)
Astec Lifesciences Ltd Interest Coverage Ratios (%)
Astec Lifesciences Ltd Valuation Ratios
Strength and Weakness of Astec Lifesciences Ltd Stock
Unable to fetch valid data for stock valuation.